Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2930033rdf:typepubmed:Citationlld:pubmed
pubmed-article:2930033lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:2930033lifeskim:mentionsumls-concept:C0036945lld:lifeskim
pubmed-article:2930033lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2930033lifeskim:mentionsumls-concept:C0077071lld:lifeskim
pubmed-article:2930033lifeskim:mentionsumls-concept:C0321946lld:lifeskim
pubmed-article:2930033pubmed:issue3lld:pubmed
pubmed-article:2930033pubmed:dateCreated1989-4-26lld:pubmed
pubmed-article:2930033pubmed:abstractTextEfficacy of oral administration of 20 mg of triclabendazole/kg of body weight was evaluated against 12-week Fascioloides magna infections in 12 sheep, each inoculated orally with 250 viable metacercariae. From 6 sheep treated with triclabendazole, 1 immature F magna was recovered, whereas 116 F magna with a mean length of 19 +/- 6.5 mm were recovered from 6 untreated control sheep. Efficacy of triclabendazole was 99.14%. Signs of toxicosis or illness were not observed in the sheep.lld:pubmed
pubmed-article:2930033pubmed:languageenglld:pubmed
pubmed-article:2930033pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2930033pubmed:citationSubsetIMlld:pubmed
pubmed-article:2930033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2930033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2930033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2930033pubmed:statusMEDLINElld:pubmed
pubmed-article:2930033pubmed:monthMarlld:pubmed
pubmed-article:2930033pubmed:issn0002-9645lld:pubmed
pubmed-article:2930033pubmed:authorpubmed-author:ForeytW JWJlld:pubmed
pubmed-article:2930033pubmed:issnTypePrintlld:pubmed
pubmed-article:2930033pubmed:volume50lld:pubmed
pubmed-article:2930033pubmed:ownerNLMlld:pubmed
pubmed-article:2930033pubmed:authorsCompleteYlld:pubmed
pubmed-article:2930033pubmed:pagination431-2lld:pubmed
pubmed-article:2930033pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:meshHeadingpubmed-meshheading:2930033-...lld:pubmed
pubmed-article:2930033pubmed:year1989lld:pubmed
pubmed-article:2930033pubmed:articleTitleEfficacy of triclabendazole against experimentally induced Fascioloides magna infections in sheep.lld:pubmed
pubmed-article:2930033pubmed:affiliationDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164.lld:pubmed
pubmed-article:2930033pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2930033pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed